Personalized Low Blood Sugar Treatment Study in Adults With Type 2 Diabetes
Tests personal low blood sugar treatment choices in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study
Key facts
- Where
- Ottawa, CanadaSee the site
Where in Canada
- The Ottawa HospitalOttawa, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ottawa Hospital Research Institute
- Trial code
- NCT07094529
- Record updated
- 30 July 2025
- Original description
This study will offer two study interventions designed to bring on a mild low blood sugar (capillary blood glucose result 3.0 to 3.8 mmol/L), in order to study the effectiveness of each study participant's personal choice of treatment and first recheck time.Read full original descriptionShow less
The Feasibility of Personalized Hypoglycemia Outpatient Treatment for People Living With Type 2 Diabetes Mellitus
This study will offer two study interventions designed to bring on a mild low blood sugar (capillary blood glucose result 3.0 to 3.8 mmol/L), in order to study the effectiveness of each study participant's personal choice of treatment and first recheck time.
The two study interventions that the participant can choose to complete (one or both interventions).
Based on each participant's own experience with hypoglycemia treatment or their preferences, the participant can choose one of 4 simple carbohydrate treatment quantities, and choose one of 4 capillary blood glucose recheck times.
Inclusion: In order to be eligible to participate in this study, an individual must meet all of the following criteria:; Consent provided; Age >= 18 years; Diagnosed as type 2 diabetes mellitus; Type 2 diabetes medications include at least one of the following for at least one month prior to entering the study: sulfonylurea or insulin of any type.
Exclusion: An individual who meets any of the following criteria will be excluded from participation in this study:; Diagnosed as another form of diabetes mellitus; Has a history of hypoglycemia unawareness; Had a hypoglycemia event, defined as capillary blood glucose < 3.9 mmol/L within 24 hours prior to the study visit booking time.